Related Experiment Video
Updated: Dec 5, 2025
12:24
Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
7.3K
Understanding IGF-II Action through Insights into Receptor Binding and Activation
Andrew J Blyth1, Nicholas S Kirk2,3, Briony E Forbes1
1Department of Medical Biochemistry, Flinders Health and Medical Research Institute, Flinders University, Bedford Park 5042, Australia.
Cells
|October 15, 2020
Summary
Insulin-like growth factor II (IGF-II) promotes cancer growth by signaling through IGF-1R and IR-A. New cryo-EM structures reveal IGF-II
Area of Science:
- Endocrinology and Molecular Biology
- Cancer Research
Background:
- The insulin-like growth factor (IGF) system regulates crucial metabolic and mitogenic processes.
- Insulin-like growth factor II (IGF-II) is vital for fetal development and implicated in cancer progression.
- IGF-II uniquely interacts with both IGF-1R and insulin receptor isoform A (IR-A).
Purpose of the Study:
- To review recent advancements in IGF-II research, focusing on its role in cancer.
- To present structural insights into IGF-II binding with its cognate receptors.
- To identify key questions for developing IGF-II antagonists in cancer therapy.
Main Methods:
- Review of current literature on the IGF system and IGF-II.
- Analysis of cryo-electron microscopy (cryoEM) structures of IGF-II bound to IGF-1R.
- Comparative structural analysis with insulin and IGF-I bound to their receptors.
Main Results:
- Determination of the cryo-electron microscopy (cryoEM) structure of IGF-II bound to IGF-1R.
- Structural comparisons highlight unique binding characteristics of IGF-II.
- IGF-II's dual receptor interaction (IGF-1R and IR-A) is confirmed.
Conclusions:
- Understanding IGF-II's structure-function relationship is critical for cancer research.
- Further investigation into IGF-II's mechanism of action is needed.
- Developing IGF-II antagonists holds therapeutic potential for treating cancers.
Keywords:
IGF-1RIGF-IIIR-Ainsulin receptorinsulin-like growth factorreceptor activationstructural studiesMore Related Videos
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
2.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.2K
01:16TGF - β Signaling Pathway
9.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.8K
01:15Amplifying Signals via Second Messengers
7.8K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
7.8K
01:29The Two-State Receptor Model
2.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.9K
01:26Signal Transduction: Overview
10.8K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Typically, signal transduction involves three...
10.8K
01:12What are Second Messengers?
88.6K
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
88.6K